This website uses cookies to enhance the user experience.
N

NUMAN HOLDING AS921 474 075

Research
Limited company
Kirkegårdsvegen 10 9009 TROMSØ, Norge

NUMAN HOLDING AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
7 years
since Sep 28, 2018
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
1,200
1 share class
Total number of shareholders
3
persons
Belongs to group of

Financials

Annual total result 2024
168,995
NOK
Total equity 2024
620,634
NOK
Last update: Jul 14, 2025

Management

Board

NameRoleShares
Chairman
33.33 %
directly
Board Member
33.33 %
directly
Board Member
33.33 %
directly

Top 10 individual shareholders

NameRoleShares
Chairman
33.33 %
directly
Board Member
33.33 %
directly
Board Member
33.33 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
400
33.33 %
Ordinary shares
400
33.33 %
Ordinary shares
400
33.33 %

Shares owned by the NUMAN HOLDING AS

NameShare classTotal number of sharesShare
H
HUDCELLEKLINIKKEN AS
Ordinary shares
30,000
100 %
Ordinary shares
300
100 %
E
EMEDIC AS
Ordinary shares
30,000
100 %
S
STUDIO - 7 AS
Ordinary shares
150,000
50 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2024: NOK 0
    Operating profit 2024: NOK -100,784
    Employees: 0

Financials

in NOK

Summary

Year2024202320222021
Total operating income
0
0
0
0
Annual Total Result
168,995
73,486
-934,154
-42,142
Total assets
620,634
451,639
408,153
1,626,110
Total liabilities
0
0
0
1,006,865
Total equity
620,634
451,639
408,153
619,245

P&L

Year2024202320222021
Total operating income
0
0
0
0
Total operating costs
100,784
86,324
60,362
42,142
Operating result
-100,784
-86,324
-60,362
-42,142
Financial income/costs
269,779
159,810
-873,792
0
Profit before tax
168,995
73,486
-934,154
-42,142
Total tax & extraordinary income/cost
0
0
0
0
Annual Total Result
168,995
73,486
-934,154
-42,142

Balance overview

Year2024202320222021
Total fixed assets
205,000
60,000
30,000
30,000
Total current assets
415,634
391,639
378,153
1,596,110
Total assets
620,634
451,639
408,153
1,626,110
Short term debt
0
0
0
1,006,865
Long term debt
0
0
0
0
Total liabilities
0
0
0
1,006,865
Contributed capital
30,000
30,000
30,000
30,000
Retained earnings
590,634
421,639
378,153
589,245
Total equity
620,634
451,639
408,153
619,245
Total equity and liabilities
620,634
451,639
408,153
1,626,110

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology